Nov 10, 2015
The new interim report on the UK's Accelerated Access Review, which aims to speed up access to innovation in the NHS, is lacking in detail, writes Leela Barham.
Nov 08, 2015
Some of the radical thinking on healthcare spending from a new EC specialist group offers robust food for thought, writes Reflector.
Oct 08, 2015
Pharmaceutical Executive
Leela Barham talks with the EMA's top medical officer, Hans-Georg Eichler, about a potentially game-changing drug approval program.
Oct 06, 2015
No-one can say England's Accelerated Access Review, which aims to “ensure that the UK is the fastest place in the world for the design, development and widespread adoption of medical innovations" isn't aiming high, writes Leela Barham.
Oct 05, 2015
Reflector outlines the current measures European countries are working or collaborating on to achieve a better understanding of pricing issues.
Oct 01, 2015
Nick Hicks looks at the challenges of devising a patient advocacy strategy amid the complex political, cultural and regulatory landscape of Russia and CIS.
Aug 27, 2015
France's bid to regain its influence reveals how far Europe is from fully achieving regulatory convergence, writes Reflector.
Aug 17, 2015
By Pharmaceutical Executive Editors
The move towards centralization and harmonization means that the regulatory and pharmacovigilance functions can no longer work independently, writes Markus Dehnhardt, Ph.D.
Jul 16, 2015
There are evident challenges for pharma in the ongoing Greek crisis. But, writes Reflector, there are some less evident challenges which may, over time, prove to be more difficult for the industry to cope with.
lorem ipsum